Chemotherapy, Checkpoint Inhibitor, and Targeted Therapies Likely to Cause Diarrhea
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.3.1074Copied!
Version20190227Copied!
PublisherOncology Nursing Society StewardDate2019-02-27T01:00:10-05:00Purpose(Clinical Focus: This value set contains concepts related to generic chemotherapies and other cancer treatment drugs which are likely to cause diarrhea in patients.),(Data Element Scope: This value set would use the Medication QDM category.),(Inclusion Criteria: This value set includes a variety of chemotherapies, checkpoint inhibitors and targeted therapies which may cause diarrhea.),(Exclusion Criteria: Brand name drugs and those not prescribable for humans have been excluded from this value set.)
Expansion
| Code | Display | System |
|---|---|---|
| 977438 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 845515 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1430451 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 977434 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 403879 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 349472 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1424918 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1657658 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1243004 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1790161 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 867502 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1541890 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 845507 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1119400 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1425116 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1657066 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1723193 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1098418 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 672149 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1657005 | http://www.nlm.nih.gov/research/umls/rxnorm |
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.1092
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.1092" ]
} ]
},
"date" : "2019-02-27T01:00:10-05:00",
"meta" : {
"versionId" : "5",
"lastUpdated" : "2019-02-27T01:00:10.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "Oncology Nursing Society Steward",
"jurisdiction" : [ {
"extension" : [ {
"valueString" : "UNKNOWN",
"url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
} ]
} ],
"purpose" : "(Clinical Focus: This value set contains concepts related to generic chemotherapies and other cancer treatment drugs which are likely to cause diarrhea in patients.),(Data Element Scope: This value set would use the Medication QDM category.),(Inclusion Criteria: This value set includes a variety of chemotherapies, checkpoint inhibitors and targeted therapies which may cause diarrhea.),(Exclusion Criteria: Brand name drugs and those not prescribable for humans have been excluded from this value set.)",
"name" : "ChemotherapyCheckpointInhibitorAndTargetedTherapiesLikelyToCauseDiarrhea",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1098416",
"display" : "vandetanib 100 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1098418",
"display" : "vandetanib 300 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1119400",
"display" : "everolimus 7.5 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1147223",
"display" : "vemurafenib 240 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1148498",
"display" : "crizotinib 200 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1148504",
"display" : "crizotinib 250 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1243004",
"display" : "axitinib 1 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1243012",
"display" : "axitinib 5 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1298948",
"display" : "14 ML pertuzumab 30 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1308428",
"display" : "everolimus 2 MG Tablet for Oral Suspension",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1308430",
"display" : "everolimus 3 MG Tablet for Oral Suspension",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1308432",
"display" : "everolimus 5 MG Tablet for Oral Suspension",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1312402",
"display" : "regorafenib 40 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1363273",
"display" : "cabozantinib 20 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1363281",
"display" : "cabozantinib 80 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1363312",
"display" : "{84 (cabozantinib 20 MG Oral Capsule) / 28 (cabozantinib 80 MG Oral Capsule) } Pack",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1363409",
"display" : "{28 (cabozantinib 20 MG Oral Capsule) / 28 (cabozantinib 80 MG Oral Capsule) } Pack",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1364580",
"display" : "{84 (cabozantinib 20 MG Oral Capsule) } Pack",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1424916",
"display" : "dabrafenib 50 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1424918",
"display" : "dabrafenib 75 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1425104",
"display" : "trametinib 0.5 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1425116",
"display" : "trametinib 2 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1430446",
"display" : "afatinib 20 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1430451",
"display" : "afatinib 30 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1430455",
"display" : "afatinib 40 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1541890",
"display" : "sunitinib 37.5 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657005",
"display" : "40 ML ipilimumab 5 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657012",
"display" : "10 ML ipilimumab 5 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657066",
"display" : "4 ML bevacizumab 25 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657073",
"display" : "16 ML bevacizumab 25 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657658",
"display" : "50 ML cetuximab 2 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657663",
"display" : "100 ML cetuximab 2 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657703",
"display" : "5 ML panitumumab 20 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1657722",
"display" : "20 ML panitumumab 20 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1723187",
"display" : "8 ML ziv-aflibercept 25 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1723193",
"display" : "4 ML ziv-aflibercept 25 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790161",
"display" : "cabozantinib 20 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790169",
"display" : "cabozantinib 40 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790173",
"display" : "cabozantinib 60 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2046140",
"display" : "16 ML bevacizumab-awwb 25 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2046148",
"display" : "4 ML bevacizumab-awwb 25 MG/ML Injection",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2056895",
"display" : "everolimus 1 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "349472",
"display" : "gefitinib 250 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "403878",
"display" : "imatinib 100 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "403879",
"display" : "imatinib 400 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "597747",
"display" : "sorafenib 200 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "616279",
"display" : "sunitinib 12.5 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "616285",
"display" : "sunitinib 25 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "616289",
"display" : "sunitinib 50 MG Oral Capsule",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "672149",
"display" : "lapatinib 250 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "845507",
"display" : "everolimus 10 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "845515",
"display" : "everolimus 5 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "867502",
"display" : "pazopanib 200 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "867508",
"display" : "pazopanib 400 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "977427",
"display" : "everolimus 0.25 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "977434",
"display" : "everolimus 0.5 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "977438",
"display" : "everolimus 0.75 MG Oral Tablet",
"version" : "06052023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "998189",
"display" : "everolimus 2.5 MG Oral Tablet",
"version" : "06052023"
} ],
"offset" : 0,
"total" : 58,
"identifier" : "urn:uuid:1e4e6bb8-220b-4aa1-83fb-39aee5836ae3",
"timestamp" : "2023-06-29T16:18:47-04:00",
"parameter" : [ {
"name" : "count",
"valueInteger" : 1000
}, {
"name" : "offset",
"valueInteger" : 0
} ]
},
"title" : "Chemotherapy, Checkpoint Inhibitor, and Targeted Therapies Likely to Cause Diarrhea",
"extension" : [ {
"valueString" : "Oncology Nursing Society Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2022-12-15",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2019-02-27",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "84622ce0-db2f-4715-bbfa-0c804534c878",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.3.1074",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.7643.3.1074"
} ],
"version" : "20190227"
}